Mounjaro Tirzepatide 12.5mg Injection is a medication used in the treatment of type 2 diabetes. It belongs to the class of incretin mimetics and acts as a GLP-1 receptor agonist. Each box contains 4 pens for subcutaneous injection.
Tirzepatide works by mimicking the action of the hormone GLP-1, which helps regulate blood sugar levels. By activating the GLP-1 receptor, it stimulates insulin secretion and reduces glucagon secretion, leading to better blood sugar control.
The 12.5mg dosage strength is a higher dose option for individuals who require more intensive treatment for their diabetes. It is typically used in combination with diet and exercise to improve glycemic control in patients with type 2 diabetes.
Be the first to review “Mounjaro Tirzepatide 12.5mg Injection, Box Of 4 Pens”